• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Leadership in MS Rehabilitation recognized: John DeLuca, PhD, awarded 2024 Giants of MS® Honor

Bioengineer by Bioengineer
May 3, 2024
in Health
Reading Time: 3 mins read
0
John DeLuca, PhD
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

East Hanover, NJ – May 3, 2024 – John DeLuca, PhD, of Kessler Foundation was named recipient of the 2024 Giants of Multiple Sclerosis® award for rehabilitation. He was one of seven inductees announced by  NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) this week. Dr. DeLuca is senior vice president, Research and Training at the Foundation and a professor in the departments of Physical Medicine & Rehabilitation and Neurology at Rutgers New Jersey Medical School.

John DeLuca, PhD

Credit: Kessler Foundation

East Hanover, NJ – May 3, 2024 – John DeLuca, PhD, of Kessler Foundation was named recipient of the 2024 Giants of Multiple Sclerosis® award for rehabilitation. He was one of seven inductees announced by  NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) this week. Dr. DeLuca is senior vice president, Research and Training at the Foundation and a professor in the departments of Physical Medicine & Rehabilitation and Neurology at Rutgers New Jersey Medical School.

Established in 2021, the Giants of Multiple Sclerosis award honors trailblazers, innovators, and visionaries acknowledged by their colleagues for their outstanding contributions to multiple sclerosis research. Individuals named to this prestigious program have made significant contributions to the field. Nominations were requested in seven different categories, including: Advanced Practice Provider, Mental Health, Neurology, Nursing, Pharmacy, Rehabilitation, and Research. The selection committee was comprised of over 30 MS professionals.

“I am grateful for this award and the recognition from CMSC and NeurologyLive. Every day, my colleagues and I strive to make discoveries that improve the quality of life of individuals with cognitive deficits. We are developing non-invasive treatments and leveraging advanced brain imaging to understand and address MS-related cognitive impairment,” said Dr. DeLuca. “Our goal is to enhance quality of life through effective management strategies like medication, exercise, and rehabilitation. I look forward to exploring new avenues of research for many years to come,” he asserted.

Dr. DeLuca is internationally known for his research on disorders of memory and information processing in a variety of clinical populations including multiple sclerosis, traumatic brain injury, aneurysmal subarachnoid hemorrhage, and chronic fatigue syndrome. Dr. DeLuca has published more than 350 articles and book chapters in these areas, has edited seven books in neuropsychology, neuroimaging, and rehabilitation, and is a co-editor for the Encyclopedia of Clinical Neuropsychology. He has received over $40 million in grant support for his research.

The 2024 Giants of Multiple Sclerosis award ceremony will take place on May 30, 2024, at the Nashville Music City Center during the 2024 CMSC Annual Meeting.

About NeurologyLive
NeurologyLive delivers direct access to practice-changing news and expert insights directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, stroke and more.

About Consortium of Multiple Sclerosis Centers
The Consortium of Multiple Sclerosis Centers (CMSC) is the largest North American multidisciplinary membership organization dedicated to defining and advancing the standard of care of MS patients. Its mission is to promote high quality MS care through education, training, clinical research, networking, and targeted advocacy efforts. The CMSC includes a professional network of 15,500 healthcare clinicians and scientists. For more information visit www.mscare.org.

About Kessler Foundation
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research. Our scientists seek to improve cognition, mobility, and long-term outcomes, including employment, for adults and children with neurological and developmental disabilities of the brain and spinal cord including traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, and autism. Kessler Foundation also leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

Press Contacts at Kessler Foundation:
Deborah Hauss, [email protected];
Carolann Murphy, [email protected].

Stay Connected with Kessler Foundation
X (formerly known as Twitter) | Facebook | YouTube | Instagram | SoundCloud



Share12Tweet8Share2ShareShareShare2

Related Posts

Inequities in Family Engagement Within the NICU

April 1, 2026

Frailty, Malnutrition Link Falls to Daily Functioning

April 1, 2026

Dactylides D, E: Novel 22-Membered Polyol Macrolides

April 1, 2026

Cutting-Edge “Smart” Drugs Revolutionize Cancer Treatment

April 1, 2026

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unveiling the Biological Pathways Linking Pesticides to Cancer Risk: New Study Sheds Light on Environmental Health Impacts

Inequities in Family Engagement Within the NICU

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.